Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can an ancient herbal remedy soothe the aftermath of stone surgery?

NCT ID NCT07746219

Symptom relief Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This trial tests whether adding a traditional Chinese herbal decoction, Bushen Huoxue Simiao Formula, to standard care can ease urinary symptoms and improve quality of life for adults recovering from upper urinary tract stone surgery. Participants, aged 18 to 80, will receive either the herbal formula plus standard postoperative treatment or standard treatment alone. The study tracks urinary symptoms, lab results, and kidney function to see if the herbal approach offers extra benefits.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Bushen Huoxue Simiao Formula, an oral Chinese herbal decoction
What this could lead to
If effective, this herbal formula could become a standard add-on therapy to reduce urinary symptoms and improve quality of life after stone surgery.
What could go wrong
This is a small, single-center trial, and the herbal formula's benefits beyond standard care are unproven. As with any herbal product, there is a risk of side effects or interactions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Aug 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Meet the Western medicine diagnostic criteria: Patients who need lithotripsy surgery and have a double J stent (4.7F, 28 cm) placed after surgery; plain film of kidney and upper bladder indicates normal position of ureteral stent and no need for stage II surgery. 2. Meet the Traditional Chinese Medicine (TCM) diagnostic criteria. 3. Aged between 18 and 80 years old (inclusive). 4. Voluntary participation with signed informed consent. Exclusion Criteria: 1. Patients with renal insufficiency stage 4 or 5, or acute renal failure. 2. Secondary factors confirmed by examination, such as systemic lupus erythematosus or drug-induced kidney damage. 3. Does not meet the diagnosis of upper urinary tract stones. 4. Cases not within the scope of drug action. 5. Long-term use of other relevant therapeutic drugs, or inability to stop medication immediately. 6. Late-stage deformity, disability, or loss of labor ability. 7. Complicated with severe primary diseases of heart, brain, liver, hematopoietic system, endocrine system, etc., or mental illness. 8. Pregnant or lactating women. 9. Patients in critical condition. 10. Other conditions deemed unsuitable for enrollment by the researchers.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Kidney disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

impaired renal function disease kidney disorder nephrolithiasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Kidney disease Urologic injuries

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.